MENU

ASND Ascendis Pharma A/S Forecast, Technical & Fundamental Analysis

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology
ASND
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ASND
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ASND is expected to report earnings to fall 71.89% to 79 cents per share on November 11

Ascendis Pharma A/S ASND Stock Earnings Reports
Q3'26
Est.
$0.80
Q2'26
Beat
by $1.32
Q1'26
Beat
by $0.09
Q4'25
Missed
by $0.40
Q3'25
Missed
by $0.72
The last earnings report on August 13 showed earnings per share of $2.83, beating the estimate of $1.51. With 261.59K shares outstanding, the current market capitalization sits at 15.13B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAND49.602.20
+4.64%
Bandwidth
STKE1.380.03
+2.22%
Sol Strategies Inc
QGEN46.170.61
+1.34%
Qiagen NV
SGU13.010.09
+0.70%
Star Group LP
VLYPP24.89-0.03
-0.12%
Valley National Bancorp

ASND and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ORMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-0.17%
ORMP - ASND
37%
Loosely correlated
+0.97%
PTGX - ASND
36%
Loosely correlated
+0.20%
AMRN - ASND
35%
Loosely correlated
-0.34%
AXON - ASND
34%
Loosely correlated
+2.15%
TARS - ASND
34%
Loosely correlated
-1.80%
More
A.I. Advisor
published General Information

General Information

a developer of drug candidates

Industry Biotechnology

Industry
Biotechnology
Address
Tuborg Boulevard 12
Phone
+45 70222244
Employees
1189
Web
https://www.ascendispharma.com
Ascendis Pharma A/S (ASND) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com